Strategic Partnerships There is an opportunity to deepen collaborations with payer networks, pediatric provider networks, and state Medicaid programs across 13 states, given current coverage of 75,000+ annual births and the existing clinical validation framework.

Clinical Validation Strength Leverage the clinically validated, patent protected, USDA Organic platform to expand adoption among pediatric practices and health plans seeking proven early allergen introduction solutions.

Expansion Readiness Target health plans and providers in states not yet fully engaged, highlighting the program's nine allergens delivered in age-appropriate doses starting at four months to position readiness for scale across additional Medicaid programs.

Funding & Growth Utilize the recent seed funding history and strategic backing from Danone Ventures to approach new investors and strategic partners, presenting a track record of venture-backed growth and board-level insights.

Market Positioning Differentiate from competitors by emphasizing pediatrician-aligned dosing, early introduction benefits, and alignment with family health goals to win contracts with larger early-life nutrition and pediatric care distributors.